• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Outlook Therapeutics, Inc. - Common Stock (NQ:OTLK)

    1.260 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Outlook Therapeutics, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 Next >
    OTLK INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Outlook Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    From Robbins Geller Rudman & Dowd LLP
    Via Business Wire
    ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
    WHY: NEW YORK, NY - (NewMediaWire) - November 9, 2023 - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of... 
    Via NewMediaWire
    Topics Lawsuit
    OUTLOOK DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Outlook To Contact Him Directly To Discuss Their Options
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Analyst Ratings for Outlook Therapeutics
     
    Via Benzinga
    Outlook Therapeutics, Inc. (OTLK) Investor Notice: Robbins LLP Reminds Investors of Class Action Filed Against Outlook Therapeutics, Inc.
    From Robbins LLP
    Via Business Wire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Outlook Therapeutics, Inc. (OTLK) Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Outlook Therapeutics, Inc. (OTLK) Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Outlook Therapeutics, Inc. (OTLK) Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Outlook Therapeutics, Inc. (OTLK) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Outlook Therapeutics, Inc. (OTLK) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    OUTLOOK THERAPEUTICS, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Outlook Therapeutics, Inc. (NASDAQ: OTLK)
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    OUTLOOK ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Outlook Therapeutics, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces Investigation of Outlook Therapeutics, Inc. (OTLK) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    OTLK INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Outlook Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    From Robbins Geller Rudman & Dowd LLP
    Via Business Wire
    OTLK SHAREHOLDER ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK
    From The Rosen Law Firm, P.A.
    Via Business Wire
    This Analyst Upgrades Vision Disorder-Focused Outlook Therapeutics' Prospects After FDA Agreement Despite Investor Concerns
    Thursday, Outlook Therapeutics Inc (NASDAQ: OTLK) announced it completed the requested Type A Meetings with the FDA to discuss the  
    Via Benzinga
    Cyberark Software To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    Crude Oil Gains Over 2%; S&P Global Raises Profit Outlook
    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Thursday. The Dow traded up 1.51% to 33,775.43 while the NASDAQ rose 1.71% to 13,284.72.... 
    Via Benzinga
    Topics Stocks
    12 Health Care Stocks Moving In Thursday's Intraday Session
     
    Via Benzinga
    Why Is Retinal Disease-Focused Outlook Therapeutics Stock Plunging Today?
    Outlook Therapeutics Inc (NASDAQ: OTLK) shares are slumping after the company announced that it has  
    Via Benzinga
    Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders. 
    Via Benzinga
    Dow Jumps 400 Points; Starbucks Posts Upbeat Earnings
    U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 400 points on Thursday. The Dow traded up 1.21% to 33,675.91 while the NASDAQ rose 1.46% to 13,251.90. The... 
    Via Benzinga
    Topics Stocks
    Nasdaq Surges Over 1%; US Initial Jobless Claims Increase To 217,000
    U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 250 points on Thursday. Following the market opening Thursday, the Dow traded up 0.82% to 33,548.07 while the NASDAQ... 
    Via Benzinga
    Topics Stocks
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
     
    Via Benzinga
    Why Adial Pharmaceuticals Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares jumped 60.2% to $0.5101 after jumping 34% on Thursday. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
     
    Via Benzinga
    Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning! 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 7 8 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.